Albemarle Corp buy Dbs Bank
Start price
24.10.25
/
50%
€88.25
Target price
24.10.26
€103.34
Performance (%)
1.47%
Price
10.11.25
€89.55
Summary
This prediction is currently active. The BUY prediction by Dbs_Bank shows slight gains of 1.47%. This prediction currently runs until 24.10.26. The prediction end date can be changed by Dbs_Bank at any time. Dbs_Bank has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Albemarle Corp | 6.913% |
| iShares Core DAX® | -0.230% |
| iShares Nasdaq 100 | -1.780% |
| iShares Nikkei 225® | -2.684% |
| iShares S&P 500 | -0.694% |
Comments by Dbs_Bank for this prediction
In the thread Albemarle Corp diskutieren
Albemarle (NYSE:ALB) had its price target raised by analysts at Dbs Bank from $100.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat